NASDAQ: IAM
Iambic Therapeutics Inc Earnings Dates, Reports, Calls

Iambic Therapeutics earnings were N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest IAM earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IAM reported annual earnings of -$77.3M, with 61.4% growth.

IAM earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

IAM Return on Equity

Insufficient data to display

IAM Return on Assets

Insufficient data to display

Be the first to know when IAM announces earnings.

IAM Return on Capital Employed

Current Company
0%
Current Industry
-7.4%

IAM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AARD-$69.51M-$69.89MN/A-$3.21
ABVC-$6.46M-$7.11MN/A-$0.29
ABVX-$285.22M-$460.11MN/A-$5.96
ACET-$89.96M-$98.97MN/A-$10.46
TRXBN/AN/AN/AN/A

Iambic Therapeutics Earnings Reports & History FAQ

What was IAM's earnings growth in the past year?

As of Iambic Therapeutics's earnings date in Q4 2026, Iambic Therapeutics's earnings has grown year over year. IAM earnings in the past year totalled N/A.

If you're new to stock investing, here's how to buy Iambic Therapeutics stock.

Is Iambic Therapeutics profitable or losing money?

As of the last Iambic Therapeutics earnings report, Iambic Therapeutics is currently losing money. Iambic Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was N/A, a N/A decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.